Paper
0
Nasal High-Flow Therapy for Primary Respiratory Support in Preterm Infants
Authors
Published
Sep 21, 2016
Show more
Save
Tip0
TipSave
Abstract
Treatment with nasal high-flow therapy has efficacy similar to that of nasal continuous positive airway pressure (CPAP) when used as postextubation support in neonates. The efficacy of high-flow therapy as the primary means of respiratory support for preterm infants with respiratory distress has not been proved.
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.